Dabur Pharma launches new chemotherapy treatment

Dabur Pharma on Thursday launched its new nano technology based chemotherapy agent, Nanoxel, in the country.


NEW DELHI: Dabur Pharma on Thursday launched its new nano technology based chemotherapy agent, Nanoxel, in the country.

The agent is an improved form of widely used anti-cancer drug Paclitaxel and has been approved by Drugs Controller-General of India (DGCI).

The company would start the clinical trials for the product in the US and Europe and expects to launch it there in another 18-36 months.
READ MORE
ADVERTISEMENT

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Industry › Healthcare/Biotech › Pharmaceuticals › Dabur Pharma launches new chemotherapy treatment
Text Size:AAA
Success
This article has been saved

*

+